Adaptation of the Protein Misfolding Cyclic Amplification (Pmca) Technique for the Screening of Anti-Prion Compounds

Authors

Celso S G Catumbela
Rodrigo Morales

Publication Date

6-20-2024

Journal

Scientific Reports

Abstract

Acetaminophen (APAP) is a leading cause of acute liver failure. The effect of APAP metabolite's effects in the periphery are well characterized; however, associated consequences in the brain remain poorly understood. Animal studies on this subject are few and reveal that frequent APAP intake can trigger cerebral abnormalities that vary depending on the subject's age. Alarmingly, experimental efforts have yet to examine associated consequences in elderly hosts, who correspond to the highest risk of medication overload, impaired drug clearance, and cognitive deficits. Here, we interrogated the cerebral and peripheral pathology of elderly mice submitted to monthly episodes of APAP intoxication since a young adult age. We found that weeks after the final episode of recurrent APAP exposure, mice exhibited worsened non-spatial memory deficit whereas spatial memory performance was unaltered. Interestingly, one month after the period of APAP intoxication, these mice showed increased glial burden without associated drivers, namely, blood-brain barrier disruption, cholesterol accumulation, and elevation of inflammatory molecules in the brain and/or periphery. Our experimental study reveals how recurrent APAP exposure affects the cognitive performance and cellular events in elderly brains. These data suggest that APAP-containing pharmacological interventions may foreshadow the elevated risk of neuropsychiatric disorders that afflict elderly populations.

Keywords

Animals, Acetaminophen, Cognitive Dysfunction, Mice, Astrocytes, Microglia, Male, Brain, Mice, Inbred C57BL, Blood-Brain Barrier, Aging, Disease Models, Animal, Spatial Memory

Comments

Supplementary Materials

Data Availability Statement

PMID: 38902507